TipRanks
Advertisement
Advertisement

DE:6XP Stock Latest News

Xspray Pharma Targets Q4 2026 FDA Resubmissions for Dasynoc and Nilopki
Company AnnouncementsXspray Pharma Targets Q4 2026 FDA Resubmissions for Dasynoc and Nilopki
2h ago
Xspray Pharma Highlights CML Data Differentiating Dasynoc and Nilopki
PremiumCompany Announcements
Xspray Pharma Highlights CML Data Differentiating Dasynoc and Nilopki
9d ago
Xspray Pharma to Showcase Commercial Oncology Strategy at Gothenburg Investor Update
PremiumCompany Announcements
Xspray Pharma to Showcase Commercial Oncology Strategy at Gothenburg Investor Update
17d ago
Xspray Pharma to Hold Investor Update Alongside Key Leukemia Conference
PremiumCompany Announcements
Xspray Pharma to Hold Investor Update Alongside Key Leukemia Conference
17d ago
Xspray Pharma Schedules Call After FDA Response on Lead Cancer Drug Dasynoc
PremiumCompany Announcements
Xspray Pharma Schedules Call After FDA Response on Lead Cancer Drug Dasynoc
1M ago
Xspray Pharma Gets FDA Complete Response Letter on Dasynoc, Speeds Manufacturing for 2026 Resubmission
PremiumCompany AnnouncementsXspray Pharma Gets FDA Complete Response Letter on Dasynoc, Speeds Manufacturing for 2026 Resubmission
1M ago
Xspray Pharma Bolsters Finances as FDA Decisions Loom for Nilopki and Dasynoc
Premium
Company Announcements
Xspray Pharma Bolsters Finances as FDA Decisions Loom for Nilopki and Dasynoc
2M ago
Xspray Pharma Advances FDA Reviews for Nilopki and Dasynoc Amid Manufacturing Checks
Premium
Company Announcements
Xspray Pharma Advances FDA Reviews for Nilopki and Dasynoc Amid Manufacturing Checks
3M ago
Xspray Pharma Schedules Investor Call After FDA Letter on Nilopki
PremiumCompany Announcements
Xspray Pharma Schedules Investor Call After FDA Letter on Nilopki
4M ago
Xspray Pharma Hit by FDA Setback on Nilopki but Keeps HyNap Strategy on Track
PremiumCompany Announcements
Xspray Pharma Hit by FDA Setback on Nilopki but Keeps HyNap Strategy on Track
4M ago
Xspray Pharma Staff Fully Take Up Warrants as Key U.S. Oncology Launches Near
PremiumCompany Announcements
Xspray Pharma Staff Fully Take Up Warrants as Key U.S. Oncology Launches Near
4M ago
Xspray Pharma AGM Approves Incentive Programs and New Share Issue Mandate
PremiumCompany Announcements
Xspray Pharma AGM Approves Incentive Programs and New Share Issue Mandate
5M ago
Xspray Pharma Boosts Share Capital After Oversubscribed Rights Issue
PremiumCompany AnnouncementsXspray Pharma Boosts Share Capital After Oversubscribed Rights Issue
5M ago
Xspray Pharma Secures Funding and FDA Momentum as Losses Narrow in Q1 2026
Premium
Company Announcements
Xspray Pharma Secures Funding and FDA Momentum as Losses Narrow in Q1 2026
5M ago
Xspray Pharma Raises SEK 113 Million in Oversubscribed Rights and Over-Allotment Issues
Premium
Company Announcements
Xspray Pharma Raises SEK 113 Million in Oversubscribed Rights and Over-Allotment Issues
5M ago
Xspray Wins FDA Nod on Nilopki Name, Sets Stage for Dual CML Drug Launch in U.S.
PremiumCompany Announcements
Xspray Wins FDA Nod on Nilopki Name, Sets Stage for Dual CML Drug Launch in U.S.
6M ago
Xspray Pharma convenes 2026 AGM, sets voting rules and agenda
PremiumCompany Announcements
Xspray Pharma convenes 2026 AGM, sets voting rules and agenda
6M ago
Xspray Pharma launches SEK 83m rights issue to fund oncology pipeline
PremiumCompany Announcements
Xspray Pharma launches SEK 83m rights issue to fund oncology pipeline
6M ago
Xspray Pharma’s Rights Issue Oversubscribed and Over-Allotment Expanded
PremiumCompany Announcements
Xspray Pharma’s Rights Issue Oversubscribed and Over-Allotment Expanded
6M ago
Xspray Pharma Publishes Comprehensive Annual Report for 2025
PremiumCompany AnnouncementsXspray Pharma Publishes Comprehensive Annual Report for 2025
6M ago
Xspray Pharma Launches SEK 83 Million Rights Issue to Fund Oncology Drug Launches
Premium
Company Announcements
Xspray Pharma Launches SEK 83 Million Rights Issue to Fund Oncology Drug Launches
6M ago
Xspray Pharma Wins FDA Review Slot for Dasynoc Ahead of Planned 2026 Dual Launch
Premium
Company Announcements
Xspray Pharma Wins FDA Review Slot for Dasynoc Ahead of Planned 2026 Dual Launch
7M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >